Article Sidebar

Submitted
Sep 18, 2024
Accepted
Oct 27, 2024
Published
Nov 8, 2024
Download
pdf
Statistic
Read Counter : 21 Download : 13

Downloads

Download data is not yet available.

Main Article Content

Abstract

Human Rhinovirus (HRV) is a RNA virus belonging to the Picornaviriade family that most often causes acute respiratory infections (ARI). This virus can cause dangerous infections in children, people with chronic respiratory disorders, and individuals with low immunity. This virus can infect newborns six to eight  times and adults two to four times per year. In addition, HRV is the main cause of pneumonia and bronchiolitis which can worsen the symptoms of cystic fibrosis asthma. This article also discusses the development of the HRV replication process that occurs in the respiratory tract epithelium which takes place in several stages, starting with virus attachment and ending with the release of new virions. We also analyze the stages of neutralizing antibodies (nAbs) to prevent HRV infection. Currently, there are not any authorized antiviral drugs or HRV vaccination because this virus has highly variable antigenic sites. To develop a vaccine that can protect against various HRV serotypes, a consensus sequence that combines several strains is needed.

Keywords

HRV Human Rhinovirus Pathogenesis Virology

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
1.
Murti AW, Andi Yasmon. Molecular Pathogenesis of Human Rhinovirus (HRV) Infection. EKSAKTA [Internet]. 2024Nov.8 [cited 2024Nov.15];25(04):399-411. Available from: https://eksakta.ppj.unp.ac.id/index.php/eksakta/article/view/540

References

  1. WHO. (2024). Children aged <5 years with acute respiratory infection (ARI) symptoms taken to facility (%). The Global Health Observatory. https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3147
  2. Kementerian kesehatan RI, B. K. P. K. (2023). Survery Kesehatan Indonesia (SKI) 2023 Dalam Angka. In Kementrian Kesehatan RI.
  3. Eccles, R. (2023). Common cold. Frontiers in Allergy, 4(3), 1–10.
  4. Pappas, D. E. (2020). The Common Cold (Issue January, pp. 199–202). Elsevier Ltd.
  5. I Georgieva, I., Stoyanova, A., Angelova, S., Korsun, N., Stoitsova, S., & Nikolaeva-Glomb, L. (2023). Rhinovirus Genotypes Circulating in Bulgaria, 2018–2021. Viruses, 15(7), 2018–2021.
  6. Buensalido, J. A. L. (2023). Rhinovirus ( RV ) Infection ( Common Cold ). 1–27.
  7. da Costa Souza, L., Bello, E. J. M., dos Santos, E. M., & Nagata, T. (2021). Molecular and clinical characteristics related to rhinovirus infection in Brasília, Brazil. Brazilian Journal of Microbiology, 52(1), 289–298.
  8. Baillie, V. L., Moore, D. P., Mathunjwa, A., Baggett, H. C., Brooks, A., Feikin, D. R., Hammitt, L. L., Howie, S. R. C., Knoll, M. D., Kotloff, K. L., Levine, O. S., O’Brien, K. L., Scott, A. G., Thea, D. M., Antonio, M., Awori, J. O., Driscoll, A. J., Fancourt, N. S. S., Higdon, M. M., … Madhi, S. A. (2021). Epidemiology of the rhinovirus (RV) in African and Southeast Asian children: A case-control pneumonia etiology study. Viruses, 13(7), 1–17.
  9. Gil, E., Roy, S., Best, T., Hatcher, J., & Breuer, J. (2023). Increasing rhinovirus prevalence in paediatric intensive care patients since the SARS-CoV2 pandemic. Journal of Clinical Virology, 166(July), 105555.
  10. Bizot, E., Bousquet, A., Charpié, M., Coquelin, F., Lefevre, S., Le Lorier, J., Patin, M., Sée, P., Sarfati, E., Walle, S., Visseaux, B., & Basmaci, R. (2021). Rhinovirus: A Narrative Review on Its Genetic Characteristics, Pediatric Clinical Presentations, and Pathogenesis. Frontiers in Pediatrics, 9(March), 1–8.
  11. Ganjian, H., Rajput, C., Elzoheiry, M., & Sajjan, U. (2020). Rhinovirus and Innate Immune Function of Airway Epithelium. Frontiers in Cellular and Infection Microbiology, 10(June), 1–14.
  12. Vandini, S., Biagi, C., Fischer, M., & Lanari, M. (2019). Impact of rhinovirus infections in children. Viruses, 11(6), 1–13.
  13. Real-Hohn, A., Groznica, M., Kontaxis, G., Zhu, R., Chaves, O. A., Vazquez, L., Hinterdorfer, P., Kowalski, H., & Blaas, D. (2023). Stabilization of the Quadruplex-Forming G-Rich Sequences in the Rhinovirus Genome Inhibits Uncoating—Role of Na+ and K+. Viruses, 15(4).
  14. Coultas, J. A., Cafferkey, J., Mallia, P., & Johnston, S. L. (2021). Experimental antiviral therapeutic studies for human rhinovirus infections. Journal of Experimental Pharmacology, 13, 645–659.
  15. Ljubin-Sternak, S., & Meštrović, T. (2023). Rhinovirus—A True Respiratory Threat or a Common Inconvenience of Childhood? Viruses, 15(4). https://doi.org/10.3390/v15040825
  16. Cifuente, J. O., & Moratorio, G. (2019). Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion. Frontiers in Cellular and Infection Microbiology, 9(August), 1–11.
  17. Alshrari, A. S., Hudu, S. A., Asdaq, S. M. B., Ali, A. M., Kin, C. V., Omar, A. R., Pei, C. P., & Sekawi, Z. (2021). Bioinformatics analysis of rhinovirus capsid proteins VP1-4 sequences for cross-serotype vaccine development. Journal of Infection and Public Health, 14(11), 1603–1611.
  18. Price, A. S., & Kennedy, J. L. (2022). T-helper 2 mechanisms involved in human rhinovirus infections and asthma. Annals of Allergy, Asthma and Immunology, 129(6), 681–691.
  19. Esneau, C., Duff, A. C., & Bartlett, N. W. (2022). Understanding Rhinovirus Circulation and Impact on Illness. Viruses, 14(1).
  20. Jackson, D. J., & Gern, J. E. (2022). Rhinovirus Infections and Their Roles in Asthma: Etiology and Exacerbations. Journal of Allergy and Clinical Immunology: In Practice, 10(3), 673–681.
  21. Andrup, L., Krogfelt, K. A., Hansen, K. S., & Madsen, A. M. (2023). Transmission route of rhinovirus - the causative agent for common cold. A systematic review. American Journal of Infection Control, 51(8), 938–957.
  22. Liyanage, G. (2020). Rhinovirus Infection in Children—a Narrative Review. Clinical Microbiology Newsletter, 42(24), 195–200.
  23. Castañeda-Ribeyro, A., Martins-Luna, J., Verne, E., Aguila-Luis, M. A., Silva-Caso, W., Ugarte, C., Carrillo-Ng, H., Cornejo-Tapia, A., Tarazona-Castro, Y., & del Valle-Mendoza, J. (2022). High prevalence and clinical characteristics of respiratory infection by human rhinovirus in children from Lima-Peru during years 2009- 2010. PLoS ONE, 17(7 July), 1–9.
  24. Kerr, S. Le, Mathew, C., & Ghildyal, R. (2021). Rhinovirus and cell death. Viruses, 13(4).
  25. Tao, K. P., Chong, M. K. C., Chan, K. Y. Y., Pun, J. C. S., Tsun, J. G. S., Chow, S. M. W., Ng, C. S. H., Wang, M. H. T., Chan, P. K. S., Li, A. M., & Chan, R. W. Y. (2022). Suppression of influenza virus infection by rhinovirus interference – at the population, individual and cellular levels. Current Research in Microbial Sciences, 3(June), 100147.
  26. Luka, M. M., Kamau, E., Adema, I., Munywoki, P. K., Otieno, G. P., Gicheru, E., Gichuki, A., Kibinge, N., Agoti, C. N., & James Nokes, D. (2020). Molecular epidemiology of human rhinovirus from 1-year surveillance within a school setting in rural coastal Kenya. Open Forum Infectious Diseases, 7(10), 1–14.
  27. Winconsin Department of Health Services. (2023). Rhinovirus and Enterovirus. https://www.dhs.wisconsin.gov/disease/rhino-entero.htm
  28. Alsayed, A. R., Abed, A., Khader, H. A., Hasoun, L., Al Maqbali, M., & Al Shawabkeh, M. J. (2024). The role of human rhinovirus in COPD exacerbations in Abu Dhabi: molecular epidemiology and clinical significance. Libyan Journal of Medicine, 19(1).
  29. Moriyama Miyu, Hugentobler WJ, I. A. (2020). Seasonality of Respiratory Viral Infections. Annual Review of Virology, 7(1), 83–101.
  30. Kim, J. H., Jang, J. Y., & Jang, Y. J. (2021). Human rhinovirus serotypes induces different immune responses. Virology Journal, 18(1), 1–10. https://doi.org/10.1186/s12985-021-01701-1
  31. Hudu, S. A. (2021). An Overview of Innate Immune Response to Human Rhinovirus Infection. Journal of Molecular Virology and Immunology, 2(3), 75–85.
  32. Touabi, L., Aflatouni, F., & McLean, G. R. (2021). Mechanisms of rhinovirus neutralisation by antibodies. Viruses, 13(3), 1–11.
  33. Zhang, N., Wang, L., Deng, X., Liang, R., Su, M., He, C., Hu, L., Su, Y., Ren, J., Yu, F., Du, L., & Jiang, S. (2020). Recent advances in the detection of respiratory virus infection in humans. Journal of Medical Virology, 92(4), 408–417.
  34. Lin, C. Y., Hwang, D., Chiu, N. C., Weng, L. C., Liu, H. F., Mu, J. J., Liu, C. P., & Chi, H. (2020). Increased detection of viruses in children with respiratory tract infection using PCR. International Journal of Environmental Research and Public Health, 17(2).
  35. Y Li, Y., Wang, X., Xu, R., Wang, T., Zhang, D., & Qian, W. (2023). Establishment of RT-RPA-Cas12a assay for rapid and sensitive detection of human rhinovirus B. BMC Microbiology, 23(1), 1–9.
  36. Ju, D. U., Park, D., Kim, I., Kim, S., & Yoo, H. M. (2023). Development of Human Rhinovirus RNA Reference Material Using Digital PCR.
  37. CDC. (2024). About Rhinoviruses. https://www.cdc.gov/rhinoviruses/about/index.htm
  38. Ng, K. T., Ng, L. J., Oong, X. Y., Chook, J. B., Chan, K. G., Takebe, Y., Kamarulzaman, A., & Tee, K. K. (2022). Application of a VP4/VP2-inferred transmission clusters in estimating the impact of interventions on rhinovirus transmission. Virology Journal, 19(1), 1–10.
  39. van den Braak, W. J. P., Monica, B., Limpens, D., Rockx-Brouwer, D., de Boer, M., & Oosterhoff, D. (2022). Construction of a Vero Cell Line Expressing Human ICAM1 for the Development of Rhinovirus Vaccines. Viruses, 14(10), 1–12.